Component

Histone lysine beta-hydroxybutyrylation

Context-specific entity; species, compartment and exposure are stated on each claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. R-beta-hydroxybutyrate increased histone beta-hydroxybutyrylation despite absent detectable HDAC inhibition.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Cultured-cell comparison with butyrate.
    limitations
    Beta-hydroxybutyrylation and acetylation are different modifications.
    nutrient_topic
    Fasting physiological-state collection; human protocols, cellular deprivation and refeeding are distinguished. · Fasting / abstention from energy intake
    plain_language
    A distinct histone modification can occur without proving the proposed HDAC route.
    primary_references
    Prominent action of butyrate over β-hydroxybutyrate as histone deacetylase inhibitor, transcriptional modulator and anti-inflammatory molecule. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30679586/ · DOI 10.1038/s41598-018-36941-9

    Fasting: fuel switching, nutrient sensing, ketone signaling, nutrient dependencies and refeeding (2026-09-18) · lines 408–414

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Cultured-cell comparison with butyrate. · source_derived_draft · unverified_draft

    ## fast-bhb-histone-mark A distinct histone modification can occur without proving the proposed HDAC route. R-beta-hydroxybutyrate increased histone beta-hydroxybutyrylation despite absent detectable HDAC inhibition. Model: Cultured-cell comparison with butyrate. Limitations: Beta-hydroxybutyrylation and acetylation are different modifications. Evidence access: Primary abstract Prominent action of butyrate over β-hydroxybutyrate as histone deacetylase inhibitor, transcriptional modulator and anti-inflammatory molecule. · 2019 · https://pubmed.ncbi.nlm.nih.gov/30679586/ · DOI 10.1038/s41598-018-36941-9
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards